Company Checkmate Pharmaceuticals, Inc.
Equities
CMPI
US1628181083
Biotechnology & Medical Research
Business Summary
Number of employees: 31
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Landry
DFI | Director of Finance/CFO | 60 | 31/22/31 |
Chris French
CTO | Chief Tech/Sci/R&D Officer | - | 01/16/01 |
James Wooldridge
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/19/01 |
Nouhad Husseini
BRD | Director/Board Member | - | 31/22/31 |
Kleem Chaudhary
PRN | Corporate Officer/Principal | 48 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 31/22/31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,038,218 | 21,017,113 ( 95.37 %) | 0 | 95.37 % |
Company contact information
Checkmate Pharmaceuticals, Inc.
245 Main Street 2nd floor
02142, Cambridge
+
http://www.checkmatepharma.com/Sector
1st Jan change | Capi. | |
---|---|---|
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |